Skip to main content
Dx & Vx Co., Ltd. logo

Dx & Vx Co., Ltd. — Investor Relations & Filings

Ticker · 180400 ISIN · KR7180400004 KO Manufacturing
Open in API
Filings indexed 474 across all filing types
Latest filing 2024-03-04 AGM Information
Country KR South Korea
Listing KO 180400

About Dx & Vx Co., Ltd.

https://www.dxvx.com/

Dx & Vx Co., Ltd. is a bio-healthcare company specializing in diagnostics and vaccine development. Its diagnostics division offers molecular diagnostic solutions, genomics and bioinformatics services, and customized companion diagnostics (CDx), leveraging an AI-based genome analysis platform. The company's therapeutic pipeline is centered on an innovative mRNA vaccine platform designed for long-term storage at room temperature. Key development areas include vaccines for infectious diseases, immuno-therapeutic cancer vaccines, oral treatments for obesity, and therapies for eye conditions. Additionally, Dx & Vx provides contract development, manufacturing, and sales organization (CDMO/CSO) services and commercializes microbiome-based products and health supplements.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for DXVX. It outlines the date, location, and agenda items (such as financial statement approval and director appointments). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2024-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (DXVX) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. It provides key financial highlights and reasons for the variance, which aligns with the definition of an Earnings Release (ER) as it serves as an initial announcement of financial results before the full audit is finalized. FY 2023
2024-02-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (증권선물위원회) and the Korea Exchange. This is a standard regulatory filing used to disclose insider trading or changes in share ownership by company directors or major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS).
2024-01-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Commission and the Korea Exchange. It details specific share transactions (purchases) made by an executive (Hwang Chan-yeon) of DXVX. This type of filing is a standard regulatory disclosure for insider trading/director dealings.
2023-12-28 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (closing of the shareholder register). It is under 5,000 characters and serves as a formal notification of an upcoming corporate event rather than a full report. Since it does not fit into specific categories like dividend announcements or proxy solicitations, it falls under the general regulatory filing category.
2023-12-13 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company Dx&Vx Co., Ltd. for the period ending September 30, 2023. It contains detailed company information, business descriptions, financial data, and management disclosures, which is characteristic of a comprehensive interim financial report. It is not an announcement of a report (RPA) or a simple certification, as it contains substantive financial and operational data. 9M 2023
2023-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.